Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adverse Side Effects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Not applicableStudy completedNCT01328288
What this trial is testing

Progress Pediatric Study

Who this might be right for
HIVDepression
The HIV Netherlands Australia Thailand Research Collaboration 840
Testing effectiveness (Phase 2)Study completedNCT01205503
What this trial is testing

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Who this might be right for
Breast CancerNon-Hodgkin's Lymphoma
Mara Chambers 32
Post-approval studies (Phase 4)UnknownNCT05478382
What this trial is testing

Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects

Who this might be right for
Postoperative PainPregabalinSpine Surgery+1 more
Ajou University School of Medicine 132
Not applicableEnded earlyNCT01865903
What this trial is testing

Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS)

Who this might be right for
Weight LossCachexia
Oslo University Hospital 17
Post-approval studies (Phase 4)Study completedNCT05074823
What this trial is testing

Comparing Three Different Doses of Intrathecal Ketamine

Who this might be right for
Ketamine Causing Adverse Effects in Therapeutic Use
Assiut University 105
Not applicableUnknownNCT05630313
What this trial is testing

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Who this might be right for
Vaccine-induced Thrombotic Thrombocytopenia SyndromeGuillain-Barre SyndromeAcute Disseminated Encephalomyelitis+1 more
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 100
Not applicableStudy completedNCT01174862
What this trial is testing

Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery

Who this might be right for
Coronary Artery Bypass Graft Triple VesselMyocardial IschemiaThrombosis+1 more
University Hospital, Basel, Switzerland 304
Testing effectiveness (Phase 2)Study completedNCT03266146
What this trial is testing

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Who this might be right for
Drug-induced Liver Injury,Chronic
Beijing 302 Hospital 90
Post-approval studies (Phase 4)UnknownNCT01588873
What this trial is testing

Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome

Who this might be right for
Adverse Effect of Oral Contraceptives, Sequela
University of Oulu 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT05175274
What this trial is testing

Colchicine Use for Primary Prevention of Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Qingdao Central Hospital 6,792
Post-approval studies (Phase 4)Study completedNCT00492518
What this trial is testing

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy

Who this might be right for
Contrast Induced NephropathyKidney DiseasesRenal Failure+1 more
Technical University of Munich 254
Large-scale testing (Phase 3)Not Yet RecruitingNCT07833514
What this trial is testing

Misocholic Tablets for Non-Viral Elevated Liver Enzymes

Who this might be right for
Alcohol-Related Liver DiseaseDrug-Induced Liver InjuryNon-alcoholic Fatty Liver Disease
Hanoi Medical University 60
Not applicableWithdrawnNCT03964584
What this trial is testing

Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real Life

Who this might be right for
HIV+ Patients
Fondation Ophtalmologique Adolphe de Rothschild
Not applicableUnknownNCT03091244
What this trial is testing

Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.

Who this might be right for
Drug-Induced Liver Injury
Beijing 302 Hospital 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04552704
What this trial is testing

CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study

Who this might be right for
Advanced Malignant Solid Neoplasm
Tianhong Li 3
Early research (Phase 1)Study completedNCT02829307
What this trial is testing

A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects

Who this might be right for
Drug-Related Side Effects and Adverse Reactions
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800
Testing effectiveness (Phase 2)Looking for participantsNCT04641247
What this trial is testing

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Who this might be right for
Ovarian NeoplasmsBreast Neoplasms
GlaxoSmithKline 37
Next Page